On March 31, 2026, Zeo ScientifiX, Inc. (OTCQB: ZEOX) announced its role as the official educational partner for regenerative medicine with the American Academy of Anti-Aging Medicine (A4M) at the upcoming Longevity SpringFest 2026. This partnership is significant as it positions Zeo alongside other leading companies in the longevity sector, such as Niagen Bioscience (NASDAQ: NAGE). The collaboration will feature a specialized, full-day Masterclass on regenerative and longevity medicine, scheduled for April 9, 2026, in West Palm Beach, Florida. This Masterclass aims to provide evidence-based training to physicians, enhancing their understanding and implementation of regenerative medicine practices. Dr. George C. Shapiro, Chief Medical Officer of Zeo, expressed enthusiasm about the initiative, emphasizing the importance of rigorous, evidence-based education in advancing the field. The partnership grants Zeo access to A4M's extensive network of over 26,000 physicians and healthcare practitioners across more than 120 countries, potentially expanding its influence and market reach in the burgeoning $29.9 billion longevity therapy market. This strategic move is expected to enhance Zeo's visibility and credibility in the regenerative medicine space, likely leading to increased interest from investors and healthcare professionals alike.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.